How the Los Angeles Times shilled for the racist eugenics movement
By Alexandra Minna Stern,
Los Angeles Times
| 02. 28. 2021
Last month, Caltech announced that the names of six men with historical ties to the university would be removed from all“campus buildings, assets, and honors.”This unnaming came as the institution renounced its historical connections to the Human Betterment Foundation, a zealous pro-eugenics organization that influenced and admired Nazi racial hygiene policies in the 1930s and 1940s. Caltech determined that prominent trustees of the foundation, such as Caltech’s inaugural president and Nobel laureate Robert A. Millikan, no longer deserved to be commemorated at the university.
Also among the six whose names will be scrubbed from Caltech was Harry Chandler, who served as publisher of the Los Angeles Times from 1917 until his death in 1944.
Caltech was correct to recognize the pivotal role of the Human Betterment Foundation in spreading the eugenics gospel. The brainchild of wealthy agribusinessman Ezra Gosney, the foundation — through its biased studies, cherry-picked data collection, propagandizing and political sway — was instrumental in making California the most aggressive sterilizer of any of the 32 U.S. states that passed eugenic sterilization laws. From 1909 to...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...